HDAC1/2 inhibitor therapy improves multiple organ systems in aged mice
Alessandra Tammaro(Amsterdam Neuroscience), Georges E. Janssens(Amsterdam University Medical Centers)
Cited by 12
Related Papers
From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs
|EMBO Molecular Medicine|2019|118
Plasma triacylglycerol length and saturation level mark healthy aging groups in humans
|GeroScience|2024|2
NNMT promotes tubular senescence and fibrosis in chronic kidney disease
|bioRxiv (Cold Spring Harbor Laboratory)|2025|2